Non-adherence to anti-tuberculosis treatment and determinant factors among patients with tuberculosis in northwest Ethiopia

Akilew Awoke Adane, Kefyalew Addis Alene, Digsu Negese Koye, Berihun Megabiaw Zeleke, Akilew Awoke Adane, Kefyalew Addis Alene, Digsu Negese Koye, Berihun Megabiaw Zeleke

Abstract

Background: Non-adherence to anti tuberculosis treatment is one of the crucial challenges in improving tuberculosis cure-rates and reducing further healthcare costs. The poor adherence to anti-tuberculosis treatment among patients with tuberculosis is a major problem in Ethiopia. Hence, this study assessed level of non-adherence to anti-tuberculosis therapy and associated factors among patients with tuberculosis in northwest Ethiopia.

Methods: An institution based cross-sectional survey was conducted among tuberculosis patients who were following anti-tuberculosis treatment in North Gondar zone from February 20--March 30, 2013. Data were collected by trained data collectors using a structured and pre-tested questionnaire. Data were entered to EPI INFO version 3.5.3 and analyzed using statistical package for social sciences (SPSS) version 20. Multiple logistic regressions were fitted to identify associations and to control potential confounding variables. Odds ratio (OR) with 95% confidence interval was calculated and p-values<0.05 were considered statistically significant.

Results: A total of 280 tuberculosis patients were interviewed; 55.7% were males and nearly three quarters (72.5%) were urban dwellers. The overall non-adherence for the last one month and the last four days before the survey were 10% and 13.6% respectively. Non-adherence was high if the patients had forgetfulness (AOR 7.04, 95% CI 1.40-35.13), is on the continuation phase of chemotherapy (AOR: 6.95, 95% CI 1.81-26.73), had symptoms of tuberculosis during the interview (AOR: 4.29, 95% CI 1.53-12.03), and had co-infection with HIV (AOR: 4.06, 95% CI 1.70-9.70).

Conclusions: Non-adherence to anti-tuberculosis treatment was high. Forgetfulness, being in the continuation phases of chemotherapy, having symptoms of tuberculosis during the interview, and co-infected with HIV were significantly associated with non-adherence to anti-tuberculosis therapy. Special attention on adherence counseling should be given to symptomatic patients, TB/HIV co-infected patients, and those in the continuation phase of the tuberculosis therapy.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Reasons of anti-TB pills missing,…
Figure 1. Reasons of anti-TB pills missing, North Gondar zone, Northwest Ethiopia, May 2013.

References

    1. Fauci A, Kasper D, Braunwald E (2008) Tuberculosis Harrison’s principle of internal medicine 17th ed. United States of America: The McGraw-Hill Companies.
    1. Organization WH (2012) WHO policy on collaborative TB/HIV activities Guidelines for national programmes and other stakeholders. Geneva, Switzerland. 36 p.
    1. Organisation WH (2011) WHO Report 2011 | Global Tuberculosis Control. France WHO. 258 p.
    1. Ethiopia FMoH (2008) Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme. Addis Ababa, Ethiopia 207 p.
    1. Sabate E (2003) Adhernece to long-term therapies: Evidence for action. Geneva, Switzerland: WHO.
    1. Harries A, Maher D, Graham S (2004) TB/HIV:A CLINICAL MANUAL. Genva World Health Organization 212 p.
    1. Awofeso N (2008) Antituberculous medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bulletin of WHO 86.
    1. Castelnuovo B (2010) A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci 10: 320–324.
    1. Organization WH (2010) Antiretroviral therapy for HIV infection in adults and adolescents recommendations for a public health approach. Geneva Siwzerland WHO.
    1. de Steenwinkel JE, ten Kate MT, de Knegt GJ, Verbrugh HA, Aarnoutse RE, et al. (2012) Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56: 4937–4944.
    1. Rocha M, Pereira S, Ferreira L, Barros H (2003) The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. Eur Respir J 21: 785–788.
    1. Kebede A, Wabe NT (2012) Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west ethiopia. N Am J Med Sci 4: 67–71.
    1. Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN (2009) Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors. Afr Health Sci 9 Suppl 1S8–15.
    1. Sardar P, Jha A, Roy D, Roy S, Guha P, et al. (2010) Intensive phase non-compliance to anti tubercular treatment in patients with HIV-TB coinfection: a hospital-based cross-sectional study. J Community Health 35: 471–478.
    1. Weiguo X, Wei L, Zhou Y, Zhu L, Shen H, et al. (2009) Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Services Research 9: 1472–6963.
    1. Gebremariam MK, Bjune GA, Frich JC (2010) Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health 10: 651.
    1. Shargie EB, Lindtjorn B (2007) Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med 4: e37.
    1. Garrido Mda S, Penna ML, Perez-Porcuna TM, de Souza AB, Marreiro Lda S, et al. (2012) Factors associated with tuberculosis treatment default in an endemic area of the brazilian Amazon: a case control-study. PLoS One 7: e39134.
    1. Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, et al. (2011) Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health 11: 696.
    1. Govender S, Mash R (2009) What are the reasons for patients not adhering to their anti-TB treatment in a South African district hospital? SA Fam Pract 51: 512–516.
    1. Abula T, Worku A (2001) patient non compliance with drug regimens for chronic diseaes in northweat Ethiopia. EthiopJHealth Dev 15: 185–192.

Source: PubMed

3
S'abonner